809 — Global Bio-chem Technology Co Balance Sheet
0.000.00%
- HK$605.70m
- HK$5.97bn
- HK$1.37bn
Annual balance sheet for Global Bio-chem Technology Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 79.5 | 153 | 21.8 | 41.8 | 316 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 843 | 787 | 356 | 279 | 396 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,453 | 1,242 | 592 | 688 | 970 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,774 | 6,354 | 5,887 | 5,158 | 4,220 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8,235 | 7,602 | 6,483 | 5,850 | 5,209 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,330 | 12,360 | 12,036 | 13,506 | 8,396 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 12,433 | 13,463 | 13,000 | 13,389 | 9,246 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | -4,198 | -5,861 | -6,518 | -7,539 | -4,037 |
Total Liabilities & Shareholders' Equity | 8,235 | 7,602 | 6,483 | 5,850 | 5,209 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |